Get the Stockscreener App
29.86
0.03%
-0.08
ARK Genomic Revolution ETF stock is traded at $29.86, with a volume of 1.87M.
It is down -0.03% in the last 24 hours and up +12.73% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$29.94
Open:
$30.35
24h Volume:
1.87M
Relative Volume:
0.68
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+10.57%
1M Performance:
+12.73%
6M Performance:
-6.70%
1Y Performance:
+43.89%
1-Day Range:
$29.32
$30.47
1-Week Range:
$26.35
$30.47
52-Week Range:
$20.21
$34.39
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
29.86 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.88 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
701.26 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
704.51 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
279.19 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
640.34 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
TEM Stock: Tempus AI Aims for 25% Growth - CMC Markets
Accessing the World of Genetics - Stock Investor
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names - MSN
Technical Reactions to ARKG Trends in Macro Strategies - Stock Traders Daily
Best Biotech ETFs for 2026 and How to Invest in Them - The Motley Fool
The personalized biotech flywheel Cathie Wood built is still a winning bet today - MSN
Cathie Wood Buys the Dip in GeneDx (WGS); Wall Street Sees 142% Upside - TipRanks
Trending Industry Today: ARK Blockchain & Fintech Innovation ETF Leads Gains In ARK ETFs Stocks - 富途牛牛
Cathie Wood's weekly moves signal shift to AI, precision medicine (ARKK:BATS) - Seeking Alpha
Cathie Wood chooses medical AI over Mark Zuckerberg: Ark loads up on TEM stock, dumps Meta shares - MSN
ARK Autonomous Technology & Robotics ETF (ARKQ) stock price, news, quote and history - Yahoo Finance Singapore
Cathie Wood's Called It Years Ago – Illumina Is the Must-Own Personalized Biotech Stock - Money Morning
The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today - AOL.com
ARK Next Generation Internet ETF (ARKW) stock price, news, quote and history - Yahoo Finance Australia
Trading the Move, Not the Narrative: (ARKG) Edition - Stock Traders Daily
Trending Industry Today: ARK Genomic Revolution ETF Leads Gains In ARK ETFs Stocks - moomoo.com
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play - Yahoo Finance
Cathie Wood sold Circle before it crashed, then bought the dip. Here’s why the crypto world is watching - AOL.com
Cathie Wood further reduces holdings in Nvidia, Meta, and other tech stocks, increases investment in the healthcare sector - Bitget
Cathie Wood has further reduced holdings in technology stocks such as NVIDIA and Meta, while increasing investments in the healthcare sector. - 富途牛牛
Here's ARK Innovation ETF's Vision for the Future. Do You Agree With It? - AOL.com
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares - AOL.com
Cathie Wood buys $2 million of tumbling AI stock - MSN
Trending Industry Today: ARK Genomic Revolution ETF Leads Losses In ARK ETFs Stocks - Moomoo
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays - Stocktwits
Beam Therapeutics Gains On Clinical Update As Gene Therapy Hits Protective Protein Levels - Sahm
Cathie Wood’s ARK Sells Meta Shares. It’s Buying This AI Stock Instead. - Barron's
Cathie Wood's Ark Invest Sells More Meta Shares - AASTOCKS.com
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor - Intellectia AI
Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names - MSN
Cathie Wood's weekly recap: adds to AMZN, BABA, HOOD, COIN, cuts TSM, BIDU - MSN
Cathie Wood sells Peter Thiel-backed crypto stock twice in a row - aol.com
ARK plans first active ETF not run by Cathie Wood - Citywire
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.22%
0.30%
Cap:
|
Volume (24h):